Shanghai, China

Zhenya Zeng

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Shanghai Haiyan Pharmaceutical Technology Co., Ltd., Yangtze River Pharmaceutical Group Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhenya Zeng. Retrieved from https://idiyas.com/inventor/zhenya-zeng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0



Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Zhenya Zeng: Pharmaceutical Formulation Inventor

Introduction

Zhenya Zeng is an inventor associated with pharmaceutical research and development in Shanghai, China. The supplied information identifies her as a woman and credits her with 1 patent.

Latest Patents

Zeng’s patent, “Solid Pharmaceutical Preparation, Preparation Method Therefor and Use Thereof,” concerns a solid pharmaceutical preparation containing an orexin receptor antagonist compound. The formulation includes an active ingredient represented by Formula I, a filler, a binder, a disintegrant, and a lubricant. The patent describes the preparation as having good dissolution, stability, and in vivo bioavailability.

Career Highlights

Zeng’s listed company affiliations include Yangtze River Pharmaceutical Group Co., Ltd. and Shanghai Haiyan Pharmaceutical Technology Co., Ltd. Her patent work focuses on pharmaceutical formulation and preparation methods.

Collaborations

The supplied information names Han Yang and Taotao Jiang as Zeng’s coworkers.

Conclusion

Zhenya Zeng’s patent reflects work on developing a stable, bioavailable solid pharmaceutical preparation, alongside professional affiliations in the pharmaceutical sector.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…